Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Am J Phys Med Rehabil ; 2023 May 18.
Article in English | MEDLINE | ID: covidwho-2324550

ABSTRACT

INTRODUCTION: Post-COVID syndrome affects relatively young outpatients with fatigue as the mostly reported symptom. We wondered whether sarcopenia could play a role. METHODS: Seventy-four outpatients (median age: 53.8 years, 45 females), reporting fatigue and persistent mild neurological/motor deficits, completed the Clinical Ultrasound and Robotic Evaluation (CURE) protocol 4.8 months after the infection. RESULTS: The incidence of sarcopenia was 41%. Sarcopenic patients were older (62.7 vs 46.4 years, p < 0.001), they experienced longer infection (33 vs 24 days, p = 0.006) and higher incidence of hospitalization (86.6 vs 29.5 %, p < 0.001), they did not report more fatigue (44.5 vs 48, p = 0.424), but they walked slower (1.27 vs 1.5 m/s, p = 0.027).After multivariable adjustment using multiple logistic regression, sarcopenia was dependent on age (OR: 1.09) and on the duration of the disease (OR: 1.04).When expressed as z-score, in 79% of patients the sway path during elastic balance shifted significantly towards negative values with closed eye, indicating multisensory integration deficit. CONCLUSION: Post-COVID syndrome in relatively young outpatients complaining mild motor deficit is associated to high incidence of sarcopenia. In addition, they suffer from multisensory integration deficit that further contributes to symptoms. The CURE protocol is able to objectivize symptoms that common diagnostic tool cannot reveal.

2.
Heart Lung ; 57: 117-123, 2023.
Article in English | MEDLINE | ID: covidwho-2031309

ABSTRACT

BACKGROUND: Vitamin D is an essential fat-soluble vitamin thought to be associated with chronic diseases, mortality and COVID-19. OBJECTIVE: To investigate the association between 25(OH) vitamin D levels and mortality of chronic diseases in subjects aged ≥65 years before and during COVID-19 pandemic. METHODS: A single-center, retrospective study was performed using the hospital database of subjects aged 65 years and older who had undergone vitamin D measurement between 01.01.2019 and 31.12.2021. All patients with vitamin D measurement (N = 2155) were followed as a cohort from the date of serum vitamin D analysis through death date or 01.01.2022. Age, gender, chronic diseases, survival status, date of death of the deceased, laboratory values including complete blood count, liver/renal functions and 25(OH) vitamin D levels were all noted. Subjects were classified into three groups according to their 25(OH) vitamin D levels; severe deficient group (<10 ng/ml), moderate deficient group (10-19.9 ng/ml), and control group (≥20 ng/ml). RESULTS: Data of 1949 subjects were included in this retrospective analysis and 206 of them (10.6%) had at least two vitamin D measurements. Until the time of data collection (01.01.2022), 94 of the cases had died within the last three years, and only five of them had repeated measurements. While the mean vitamin D level was lower, age and frequency of dyslipidemia, coronary artery disease (CAD), chronic obstructive pulmonary disease (COPD), arrhythmia, dementia and severe vitamin D deficiency (<10 ng/ml) were higher in subjectswho died (all p<0.05). According to the Cox proportional hazards model; age, presence of CAD, COPD, arrhythmia, dementia, anemia and severe vitamin D deficiency were independently related with mortality (all p<0.05). After adjusted by age, gender, and comorbidities, the probability of death was found to be 1.91 (95% CI=1.12-3.24) times higher in the severe vitamin D deficient group. CONCLUSIONS: The results of this study have shown that - after having adjusted for potential factors - severe vitamin D deficiency (<10 ng/ml) seems to be an independent predictor for non-cancer mortality. Although vitamin D measurement/treatment is very easy and cheap where, on the contrary, severe vitamin D deficiency can be quite mortal.


Subject(s)
COVID-19 , Coronary Artery Disease , Dementia , Pulmonary Disease, Chronic Obstructive , Vitamin D Deficiency , Humans , Aged , Retrospective Studies , COVID-19/epidemiology , Pandemics , Vitamin D Deficiency/complications , Vitamin D Deficiency/epidemiology , Vitamin D , Coronary Artery Disease/complications , Pulmonary Disease, Chronic Obstructive/epidemiology , Pulmonary Disease, Chronic Obstructive/complications , Dementia/epidemiology , Dementia/complications
4.
Korean J Pain ; 35(2): 233-235, 2022 Apr 01.
Article in English | MEDLINE | ID: covidwho-1771024
5.
Work: Journal of Prevention, Assessment & Rehabilitation ; 67(4):763-765, 2020.
Article in English | APA PsycInfo | ID: covidwho-1766644

ABSTRACT

Background: During the coronavirus disease (COVID-19) pandemic, people volunteered for sewing hand-made face masks. However, sewing-machine operating might be associated with high ergonomic risk and a negative impact on musculoskeletal health. Objective and Methods: This paper describes an ultrasonographic diagnosis of a foot ganglion - after sewing 300 face masks within two months using a foot-operated sewing machine. Results: The patient significantly improved after an ultrasound-guided aspiration and corticosteroid injection. Conclusion: In short, we highlight the importance of ultrasound examination in the management of work (overuse)- related disorders in occupational medicine practice. (PsycInfo Database Record (c) 2022 APA, all rights reserved)

7.
Heart Lung ; 50(6): 743-747, 2021.
Article in English | MEDLINE | ID: covidwho-1267685

ABSTRACT

BACKGROUND: Grip strength is one of the main components for the physical functioning in sarcopenia and physical frailty. OBJECTIVES: To explore the role of grip strength measurement at admission for predicting disease severity in COVID-19. METHODS: Demographic data, smoking status, comorbidities, COVID-19 related symptoms, grip strength, laboratory and computed tomography (CT) findings at admission were all noted. Using a Smedley hand dynamometer, the maximum grip strength value (kg) after three measurements on the dominant side was recorded. Low grip strength was defined as two standard deviations below the gender-specific peak mean value of the healthy young adults (<32 kg for males, <19 kg for females). Patients were categorized into three groups according to clinical and CT findings. Severe illness group had pneumonia with a respiratory rate >30/min, oxygen saturation ≤90%, or extensive lung involvement in CT. Moderate illness group had pneumonia with CT score ≤11. Mild illness group had normal CT findings. RESULTS: The study population included 312 patients (140 F, 172 M). The distribution of mild, moderate and severe disease groups were 36.9%, 51.0% and 12.2%, respectively. Cough, fever, dyspnea, hypertension, obesity, cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD) were most frequent, and C-reactive protein (CRP), ferritin, D-dimer, and neutrophil levels were highest in the severe group (all p<.05). Absolute grip strength values were lowest and the frequency of having low grip strength were highest in the severe group (both p<.01). Since we found that the significant differences were stemming from the severe group, we combined the mild and moderate group as non-severe, and compared severe vs. non-severe groups with binary logistic regression analyses. When age, gender, body mass index, smoking status, presence of comorbidities and low grip strength, and abnormal laboratory findings were taken into analyses; age (odds ratio [OR]: 1.054 [95% confidence interval (CI): 1.020-1.089]), obesity (OR: 2.822 [95% CI: 1.143-6.966]), COPD (OR: 5.699 [95 %CI: 1.231-26.383]), CRP level (OR: 1.023 [95% CI: 1.010-1.036]) and low grip strength (OR: 3.047 [95% CI: 1.146-8.103]) were observed to be independent predictors for severe COVID-19 disease (all p<.05). CONCLUSIONS: In addition to the well-known independent risk factors (i.e. age, obesity, COPD, and CRP level), low grip strength independently increased (about three times) the severity of COVID-19.


Subject(s)
COVID-19 , Pulmonary Disease, Chronic Obstructive , Female , Hand Strength , Humans , Male , SARS-CoV-2 , Severity of Illness Index , Young Adult
8.
Br J Nutr ; 124(7): 736-741, 2020 10 14.
Article in English | MEDLINE | ID: covidwho-1221093

ABSTRACT

The WHO has announced the novel coronavirus disease (COVID-19) outbreak to be a global pandemic. The distribution of community outbreaks shows seasonal patterns along certain latitude, temperature and humidity, that is, similar to the behaviour of seasonal viral respiratory tract infections. COVID-19 displays significant spread in northern mid-latitude countries with an average temperature of 5­11°C and low humidity. Vitamin D deficiency has also been described as pandemic, especially in Europe. Regardless of age, ethnicity and latitude, recent data showed that 40 % of Europeans are vitamin D deficient (25-hydroxyvitamin D (25(OH)D) levels <50 nmol/l), and 13 % are severely deficient (25(OH)D < 30 nmol/l). A quadratic relationship was found between the prevalences of vitamin D deficiency in most commonly affected countries by COVID-19 and the latitudes. Vitamin D deficiency is more common in the subtropical and mid-latitude countries than the tropical and high-latitude countries. The most commonly affected countries with severe vitamin D deficiency are from the subtropical (Saudi Arabia 46 %; Qatar 46 %; Iran 33·4 %; Chile 26·4 %) and mid-latitude (France 27·3 %; Portugal 21·2 %; Austria 19·3 %) regions. Severe vitamin D deficiency was found to be nearly 0 % in some high-latitude countries (e.g. Norway, Finland, Sweden, Denmark and Netherlands). Accordingly, we would like to call attention to the possible association between severe vitamin D deficiency and mortality pertaining to COVID-19. Given its rare side effects and relatively wide safety, prophylactic vitamin D supplementation and/or food fortification might reasonably serve as a very convenient adjuvant therapy for these two worldwide public health problems alike.


Subject(s)
Coronavirus Infections/epidemiology , Global Health , Pneumonia, Viral/epidemiology , Vitamin D Deficiency/epidemiology , Age Factors , COVID-19 , Comorbidity , Coronavirus Infections/mortality , Coronavirus Infections/therapy , Dietary Supplements , Europe/epidemiology , Humans , Pandemics , Pneumonia, Viral/mortality , Pneumonia, Viral/therapy , Vitamin D/administration & dosage , Vitamin D Deficiency/therapy
SELECTION OF CITATIONS
SEARCH DETAIL